Impact of Poloxamer 188 Material Attributes on Proteinaceous Visible Particle Formation in Liquid Monoclonal Antibody Formulations-Reference-Cited by-同舟云学术

Impact of Poloxamer 188 Material Attributes on Proteinaceous Visible Particle Formation in Liquid Monoclonal Antibody Formulations

Published:2022-08 Issue:8 Volume:111 Page:2191-2200
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Soeda Kohei,Fukuda Masakazu^ORCID,Takahashi Masaya,Imai Hirotaka,Arai Kengo^ORCID,Saitoh Satoshi,Kishore Ravuri S.K.^ORCID,Oltra Nuria Sancho^ORCID,Duboeuf Jeremy,Hashimoto Daisuke,Yamanaka Yuji

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Antibodies to watch in 2020;Kaplon;MAbs,2020

2. Next generation antibody drugs: pursuit of the 'high-hanging fruit;Carter;Nat Rev Drug Discov,2018

3. Effects of protein aggregates: an immunologic perspective;Rosenberg;AAPS J,2006

4. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics;Singh;J Pharm Sci,2010

5. Protein particles: what we know and what we do not know;Ripple;J Pharm Sci,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug product Formulation and Fill/Finish Manufacturing Process Considerations for AAV-Based Genomic Medicines;Journal of Pharmaceutical Sciences;2024-07

2. Stability of Protein Pharmaceuticals: Recent Advances;Pharmaceutical Research;2024-06-27

3. Quantification of Biopharmaceutically Relevant Nonionic Surfactant Excipients Using Benchtop qNMR;Analytical Chemistry;2024-04-18

4. High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations;Journal of Chromatography A;2024-04

5. Chain extension epoxide polymerization to well‐defined block polymers using a N‐Al Lewis pair catalyst;Journal of Polymer Science;2024-03-17